🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A previously published, placebo-controlled, head-to-head comparator study f...
Status
Completed
Location
Multiple Locations
Start Date
1996-11
Trial ID
NCT01986088
Treatments Being Tested
The objective of this study is to compare the rate and extent of absorption...
Status
Completed
Location
Biovail Contract Research
Start Date
2003-03
Trial ID
NCT00847405
Treatments Being Tested
A study to compare rizatriptan 10 mg verse sumatriptan 100 mg in the treatm...
Status
Completed
Location
Multiple Locations
Start Date
1995-09
Trial ID
NCT00898677
Treatments Being Tested
A Study to Assess the Efficacy and Safety of Oral CL-H1T in the Treatment o...
Status
Completed
Location
Suncoast Clinical Research, Inc.
Start Date
2019-02-01
Trial ID
NCT03877718
The objective of this study was to compare the relative bioavailability of ...
Status
Completed
Location
BA Research India Limited
Start Date
2005-07
Trial ID
NCT01269281
Treatments Being Tested
The primary objective is to compare the pharmacokinetics (PK) of NP101 with...
Status
Completed
Location
Orlando Clinical Research Center
Start Date
2007-11
Trial ID
NCT00546650
Treatments Being Tested
The objective of this study is to compare the rate and extent of absorption...
Status
Completed
Location
Gateway Medical Research, Inc.
Start Date
2004-08
Trial ID
NCT00846885
Treatments Being Tested
The purpose of this study is to assess whether taking lasmiditan and sumatr...
Status
Completed
Location
Covance Daytona Beach
Start Date
2017-10-17
Trial ID
NCT03310411
Treatments Being Tested
A safety and efficacy study of DFN-02 (Sumatriptan Nasal Spray 10 mg), bein...
Status
Completed
Location
Site 30
Start Date
2016-07-11
Trial ID
NCT02856802
Treatments Being Tested
Study KCC-SMT-002, is a Phase 1, single-site, open-label, non-randomized, c...
Status
Completed
Location
Carolina Phase 1 Research
Start Date
2018-01-17
Trial ID
NCT03229798
Treatments Being Tested